Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)

16.64 -0.04 (-0.27%)
Streaming Delayed Price Updated: 12:28 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Telix Pharmaceuticals Limited - American Depositary Shares

< Previous 1 2 Next >
Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent 
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Reports US$186M Q1 Revenue, Up 62% YOY
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients
Telix reports early Phase 2 data showing TLX101 improves survival in recurrent brain cancer patients, with no serious side effects observed. 
Via Benzinga
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
From Telix Pharmaceuticals Limited
Via GlobeNewswire
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?
Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty. 
Via Benzinga
Telix Announces Cardinal Health for Gozellix Commercial Distribution
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Five Below, Telix Pharmaceuticals, Dollar Tree And Other Big Stocks Moving Higher On Monday
Via Benzinga
Telix Appoints Paul Schaffer as Chief Technology Officer
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Anne Whitaker Appointed as Non-Executive Director
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
From Telix Pharmaceuticals Limited
Via GlobeNewswire
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
From Telix ARTMS, Inc.
Via GlobeNewswire
FDA Approves New Prostate Cancer Imaging Agent Gozellix®
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Adds Lead-212 Isotope Production Capability
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
From Telix Pharmaceuticals Limited
Via GlobeNewswire
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Bridge Investment Group, Telix Pharmaceuticals, Sun Communities, And Other Big Stocks Moving Higher On Monday
Via Benzinga
Stock Rebound Stalls; Nasdaq Down Triple Digits
Stocks have pulled back from their premarket gains, with the Nasdaq Composite down 163 points and oscillating in and out of negative territory for 2025. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Illuccix® Approved in the United Kingdom
From Telix Pharmaceuticals Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Completes Acquisition of RLS (USA) Inc.
From Telix Pharmaceuticals Limited
Via GlobeNewswire
SLB Posts Upbeat Results, Joins Bank OZK, Qorvo And Other Big Stocks Moving Higher On Friday
Via Benzinga
Illuccix® Receives European Approval
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
From Telix Pharmaceuticals Limited
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.